- Recommendation ID
- NG217/06
- Question
Monitoring antiseizure medications in women and girls: What is the clinical and cost effectiveness of therapeutic drug monitoring in girls, young women and women with epilepsy?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on support and monitoring for women planning pregnancy or who are pregnant.
Full details of the evidence and the committee's discussion are in evidence review 8: therapeutic drug monitoring in women and girls.
Source guidance details
- Comes from guidance
- Epilepsies in children, young people and adults
- Number
- NG217
- Date issued
- April 2022
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/04/2022 |